BNC Share Price

Open 22.09 Change Price %
High 22.09 1 Day 0.00 0.00
Low 22.09 1 Week -0.61 -2.69
Close 22.09 1 Month -0.66 -2.90
Volume 400 1 Year 21.88 10419.05
52 Week High 23.18
52 Week Low 20.15
BNC Important Levels
Resistance 2 22.09
Resistance 1 22.09
Pivot 22.09
Support 1 22.09
Support 2 22.09
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
ELD 4.22 0.00%
ELD 4.22 0.00%
TBE 0.03 0.00%
MFC 23.40 0.73%
MFC 23.40 0.73%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
BNG 0.16 23.08%
BNG 0.16 23.08%
ANX 0.08 14.29%
ANX 0.08 14.29%
More..
TSE Canada Top Losers Stocks
DA-A 0.20 -55.56%
TPL 0.02 -33.33%
TPL 0.02 -33.33%
GBV 0.46 -24.59%
CTU-A 0.19 -9.52%
GGA 0.12 -7.69%
GCL 1.10 -6.78%
GCL 1.10 -6.78%
GCL 1.10 -6.78%
DEJ 0.14 -6.67%
More..

Bioniche Life Sciences Inc (TSE: BNC)

BNC Technical Analysis 5
As on 22nd Mar 2017 BNC Share Price closed @ 22.09 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.59 & Strong Buy for SHORT-TERM with Stoploss of 10.19 we also expect STOCK to react on Following IMPORTANT LEVELS.
BNC Target for March
1st Target up-side 22.73
2nd Target up-side 22.89
3rd Target up-side 23.05
1st Target down-side 22.27
2nd Target down-side 22.11
3rd Target down-side 21.95
BNC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioniche.com
BNC Address
BNC
231 Dundas Street East
Belleville, ON K8N 1E2
Canada
Phone: 613-966-8058
Fax: 613-966-4177
BNC Latest News
Goldman Sachs rolls out junk bond ETF: Fund Scan   Financial Planning   - 25th Mar 17
TSX listed corporate dividends and distributions declared March 23   Winnipeg Free Press   - 24th Mar 17
Purpose Investments Inc. Announces March Distributions   SYS-CON Media (press release)   - 23rd Mar 17
TSX listed corporate dividends and distributions declared Feb. 22   Brandon Sun   - 23rd Feb 17
Purpose Investments Inc. Announces February Distributions   Marketwired (press release)   - 17th Feb 17
Vanguard Introduces Four Canadian Fixed Income ETFs   Canada NewsWire (press release)   - 07th Feb 17
The No-Fee ETF Portfolio Beats the Pros   The Motley Fool Canada   - 27th Dec 16
Purpose Investments Announces the Launch of Two Innovative Income Funds   Marketwired (press release)   - 26th Oct 16
Is my ETF's yield too good to be true?   The Globe and Mail   - 15th Oct 16
The market share battle between ETFs and mutual funds heating up as Canadian ...   Financial Post   - 07th Jun 16
Interactive Technical Analysis Chart Bioniche Life Sciences Inc ( BNC TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Bioniche Life Sciences Inc
BNC Business Profile
Bioniche Life Sciences Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, manufacture, and marketing of proprietary products for the human health markets. Its lead product, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, is a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans, which is in Phase III clinical development. The company was formerly known as Vetrepharm Animal Health Inc. Bioniche Life Sciences Inc. was founded in 1979 and is headquartered in Belleville, Canada.